Literature DB >> 15376309

Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor.

Charles Miller1, Sander Florman, Leona Kim-Schluger, Patrick Lento, Julia De La Garza, Josephine Wu, Boxun Xie, Wandi Zhang, Edward Bottone, David Zhang, Myron Schwartz.   

Abstract

A 57-year-old male with a history of hypercholesterolemia and anxiety but otherwise in good health volunteered to donate the right lobe of his liver to his brother. The operation was performed uneventfully, without transfusion. Postoperatively he did well, until he developed tachycardia, profound hypotension, and coffee ground emesis on postoperative day 3. Despite resuscitative measures, he arrested and expired. Autopsy demonstrated gas gangrene of the stomach as the underlying cause of the hemorrhage and numerous colonies of Gram-positive bacilli were identified. Subsequent polymerase chain reaction (PCR) analysis identified these bacteria to be Clostridium perfringens (C. perfringens) type D. This patient's death was devastating, both to his family and his medical team. The impact of his death has transcended that of an individual occurrence. In conclusion, herein we present the facts and discuss this extraordinary example of florid clostridial infection and toxin-mediated shock. It was completely unexpected and probably unpreventable, and its cause was almost inconceivable.

Entities:  

Mesh:

Year:  2004        PMID: 15376309     DOI: 10.1002/lt.20227

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  38 in total

1.  Acute Necrotizing Cholangiohepatitis With Clostridium perfringens: A Rare Cause of Post-Transplantation Mortality.

Authors:  Richard J Howard
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

2.  Living donor right liver lobe transplantation with or without inclusion of the middle hepatic vein: analysis of complications.

Authors:  Jorge Marcelo Padilla Mancero; Adriano Miziara Gonzalez; Marcelo Augusto Fontenelle Ribeiro; Gilberto Peron; Raul Carlos Wahle; Francisco Leôncio Dazzi; Adávio de Oliveira e Silva; Luiz Augusto Carneiro D'Albuquerque
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 3.  Ethical tensions in solid organ transplantation: the price of success.

Authors:  Sanjay Kulkarni; David-C Cronin
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

Review 4.  Adult-to-adult living donor liver transplantation.

Authors:  Shimul A Shah; Gary A Levy; Lesley D Adcock; Gary Gallagher; David R Grant
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

Review 5.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

Review 6.  Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

Authors:  Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

7.  Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases.

Authors:  See Ching Chan; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

Review 8.  Current concept of small-for-size grafts in living donor liver transplantation.

Authors:  Toru Ikegami; Mitsuo Shimada; Satoru Imura; Yusuke Arakawa; Akira Nii; Yuji Morine; Hirofumi Kanemura
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

9.  Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen.

Authors:  Michelle Lewis; Charles David Weaver; Mark S McClain
Journal:  Toxins (Basel)       Date:  2010-07-01       Impact factor: 5.075

10.  Donor safety in live-related liver transplantation.

Authors:  V A Wakade; S K Mathur
Journal:  Indian J Surg       Date:  2011-12-29       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.